课题基金 / 基金详情

项目摘要

项目成果

Shannon S Stahl的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案中概述的研究针对一类新的“C-H功能化”反应,涉及pd催化脂肪族碳-碳单键脱氢生成芳香族,杂芳香族和烯烃产品。这些反应应该在药物和生物活性分子的合成中具有广泛的用途。这种新的反应性将建立在有氧氧化催化的最新进展之上,使分子氧作为化学计量氧化剂/氢受体,形成水作为反应的唯一副产物。针对新型钯催化剂的开发及其合成应用的实证研究将辅以系统的机理研究,以建立有助于成功反应的基本原理。针对四类不同的反应:(1)环己酮和环己酮脱氢制备各种取代苯酚衍生物,(2)酮和其他羰基化合物脱氢制备多用途的1,2-不饱和羰基化合物,(3)环己烯脱氢制备各种取代芳烃,(4)6元氮杂环脱氢制备喹啉和吡啶衍生物。这些反应的底物可以通过多种合成途径从现成的原料中获得,包括Diels-Alder环加成、Robinson环加成和简单的缩合加成反应。这些脱氢反应的关键步骤包括PdII介导的C-H键活化,通常从相对活化的位点(例如,邻近羰基或在烯丙基位置)形成PdII-烷基中间体,然后通过2-氢化物消除产生不饱和产物和PdII-氢化物中间体。分子氧氧化PdII- h使活性PdII催化剂再生。钯催化剂的新配体的鉴定将在这项工作中发挥重要作用,因为配体在涉及有机底物的反应中调节PdII的反应活性,并在催化剂再氧化过程中稳定Pd的还原形式(Pd0和PdII- h)。总的来说,开发高效的C-C键有氧脱氢催化剂,以及为这些反应提供多种有机底物的合成途径,将为选择性取代芳香族和杂芳香族化合物提供环境友好的途径,这些化合物可以媲美或超过有机化学中一些最强大的合成转化的效用,例如金属催化的交叉偶联反应。
英文摘要
DESCRIPTION (provided by applicant): The research outlined in this proposal targets a new class of "C-H functionalization" reactions, involving Pd-catalyzed dehydrogenation of aliphatic carbon-carbon single bonds to form aromatic, heteroaromatic and alkene products. These reactions should have widespread utility in the synthesis of pharmaceuticals and biologically active molecules. This novel reactivity will build upon recent advances in aerobic oxidation catalysis to enable molecular oxygen to serve as the stoichiometric oxidant/hydrogen acceptor, forming of water as the sole byproduct of the reaction. Empirical studies directed toward the development of new Pd catalysts and investigation of their synthetic applications will be complemented by systematic mechanistic studies to establish the fundamental principles that contribute to successful reactivity. Four different classes of reactions are targeted: (1) dehydrogenation of cyclohexanones and cyclohexenones to prepare a variety of substituted phenol derivatives, (2) dehydrogenation of ketones and other carbonyl compounds to prepare versatile 1,2-unsaturated carbonyl compounds, (3) dehydrogenation of cyclohexenes to prepare a variety of substituted arenes, and (4) dehydrogenation of 6-membered nitrogen heterocycles to prepare quinoline and pyridine derivatives. Substrates for these reactions can be obtained from readily available starting materials via a number of versatile synthetic routes, including Diels-Alder cycloadditions, Robinson annulations, and simple condensation and addition reactions. Key steps in these dehydrogenation reactions include PdII-mediated activation of a C-H bond, often from a relatively activated site (e.g., adjacent to a carbonyl group or in an allylic position), to form a PdII- alkyl intermediate, followed by 2-hydride elimination to produce the unsaturated product and a PdII-hydride intermediate. Oxidation of the PdII-H species by molecular oxygen regenerates the active PdII catalyst. The identification of new ligands for the Pd catalysts will play an important role in this work because the ligands are critical to modulate the reactivity of PdII in the reactions involving the organic substrate and to stabilize the reduced forms of Pd (Pd0 and PdII-H) in the catalyst reoxidation process. Overall, the development of efficient new catalysts for aerobic dehydrogenation of C-C bonds, together with the ease of synthetic access to diverse organic substrates for these reactions, will provide environmentally benign routes to selectively substituted aromatic and heteroaromatic compounds that rival or surpass the utility of some of the most powerful synthetic transformations in organic chemistry, such as metal-catalyzed cross-coupling reactions. PUBLIC HEALTH RELEVANCE: The development of efficient methods for the synthesis of organic molecules is critical for the discovery, development and commercial production of pharmaceuticals and therapeutic agents. The research outlined in this proposal will lead to new catalytic methods for the preparation of such biologically active molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Catalytic Oxidations for Pharmaceutical Synthesis
  • 批准号:
    10541047
  • 项目类别:
  • 资助金额:
    $4.7万
  • 财政年份:
    2020
  • 负责人:
    Shannon S Stahl
  • 依托单位:
Catalytic Oxidations for Pharmaceutical Synthesis
  • 批准号:
    10319588
  • 项目类别:
  • 资助金额:
    $59.51万
  • 财政年份:
    2020
  • 负责人:
    Shannon S Stahl
  • 依托单位:
Catalytic Oxidations for Pharmaceutical Synthesis
  • 批准号:
    10797835
  • 项目类别:
  • 资助金额:
    $15.54万
  • 财政年份:
    2020
  • 负责人:
    Shannon S Stahl
  • 依托单位:
Catalytic Oxidations for Pharmaceutical Synthesis
  • 批准号:
    10078960
  • 项目类别:
  • 资助金额:
    $66.46万
  • 财政年份:
    2020
  • 负责人:
    Shannon S Stahl
  • 依托单位:
海外基金